Analysts Expect Summit Therapeutics Inc. (NASDAQ:SMMT) Will Post Earnings of -$0.29 Per Share 2021/11/05 12:28:42 Dakota Financial News
Analysts expect that Summit Therapeutics Inc. (NASDAQ:SMMT) will post ($0.29) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have made estimates for Summit Therapeutics earnings. Summit Therapeutics posted earnings of ($0.25) per share during the same quarter last year, which would indicate a negative year over year growth 
Citigroup Inc. Has $53,000 Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT) 2021/10/23 08:18:42 Dakota Financial News
Citigroup Inc. cut its stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT) by 53.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,165 shares of the companys stock after selling 8,167 shares during the period. Citigroup Inc.s holdings in Summit Therapeutics were 
Summit Therapeutics Appoints Prominent Biotech Attorney and Advisor Kenneth A. Clark to Its Board of Directors 2021/10/08 12:30:00 Intrado Digital Media
Cambridge, MA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Kenneth A. Clark, JD, has been appointed to our Board of Directors, effective immediately. Mr. Clark is currently a partner at Wilson Sonsini Goodrich & Rosati (WSGR) based out of the firms Palo Alto, CA, office.
Futures Bounce On Evergrande Reprieve With Fed Looming 2021/09/22 12:05:16 Zero Hedge
Futures Bounce On Evergrande Reprieve With Fed Looming Despite today''s looming hawkish FOMC meeting in which Powell is widely expected to unveil that tapering is set to begin as soon as November and where the Fed''s dot plot may signal one rate hike in 2022, futures climbed as investor concerns over China''s Evergrande eased after the property developer negotiated a domestic bond payment deal. Commodities rallied while the dollar was steady. Contracts on the S&P 500 and Nasdaq 100 flipped from losses to gains as Chinas central bank boosted liquidity when it injected a gross 120BN in yuan, the most since January ... and investors mulled a vaguely-worded statement from the troubled developer about an interest payment. S&P 500 E-minis were up 23.0 points, or 0.53%, at 7:30 a.m. ET. Dow E-minis were up 199 points, or 0.60%, and Nasdaq 100 E-minis were up 44.00 points, or 0.29%. Among individual stocks, Fedex fell 5.8% after the delivery company cut its profit outlook on higher costs and stalled growth in shipments.
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster 2021/07/01 12:00:00 Intrado Digital Media
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the Company) today announced that members of our scientific team will present breakthrough research updates at the 31 st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), which will be held virtually July 9 12. Our three posters to be presented are as follows, one of which was designated as a Top Rated ePoster by the ECCMID conference:
Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator 2021/06/22 17:25:45 Seeking Alpha
Summit Therapeutics set to join Russell 3000 Index 2021/06/08 11:00:00 Wallstreet:Online
Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions posted by FTSE Russell. Annual Russell indexes reconstitution captures the 4,000 largest US stocks
Summit Therapeutics set to join Russell 3000® Index 2021/06/08 00:00:00 BioSpace
Summit Therapeutics Inc. is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US markets open on June 28, according to a preliminary list of additions posted by FTSE Russell.
SUMMIT THERAPEU/S (NASDAQ:SMMT) Stock Crosses Above 50-Day Moving Average of $3.41 2020/10/20 01:00:49 Daily Political
SUMMIT THERAPEU/S (NASDAQ:SMMT) shares passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $3.41 and traded as high as $3.61. SUMMIT THERAPEU/S shares last traded at $3.47, with a volume of 60,582 shares. Separately, Zacks Investment Research cut SUMMIT THERAPEU/S from a “hold” […]
Summit Therapeutics files for $200M mixed shelf (NASDAQ:SMMT) 2020/10/06 09:46:48 Seeking Alpha
Summit Therapeutics (NASDAQ:SMMT) has filed a prospectus for a $200M mixed shelf offering.
Summit Therapeutics PLC (SMMT) Outpaces Stock Market Gains: What You Should Know 2020/05/27 21:45:15 Zacks Investment Research
Summit Therapeutics PLC (SMMT) closed at $4.20 in the latest trading session, marking a +1.94% move from the prior day.
Summit Therapeutics PLC (SMMT) Stock Moves -0.43%: What You Should Know 2020/05/19 21:45:13 Zacks Investment Research
In the latest trading session, Summit Therapeutics PLC (SMMT) closed at $3.48, marking a -0.43% move from the previous day.